This episode currently has no reviews.
Submit Review- Podcast |
- Connecting ALS
- Publisher |
- ALS Association
- Media Type |
- audio
- Publication Date |
- Jul 14, 2022
- Episode Duration |
- 00:11:23
Given the FDA’s decision to reconvene the Peripheral and Central Nervous System Drugs Advisory Committee to discuss the New Drug Application for AMX0035 for the treatment of amyotrophic lateral sclerosis, Jeremy welcomes back Dr. Neil Thakur, chief mission officer at The ALS Association, for the latest.
To urge the FDA to approve AMX0035 as quickly as possible go to als.org/fda
To read the letter from several dozen ALC clinical experts calling on FDA to make AMX0035 available as a treatment option go to https://www.als.org/stories-news/several-dozen-prominent-als-clinicians-call-fda-approve-amx0035
This episode is brought to you by The ALS Association in partnership with CitizenRacecar.
Given the FDA’s decision to reconvene the Peripheral and Central Nervous System Drugs Advisory Committee to discuss the New Drug Application for AMX0035 for the treatment of amyotrophic lateral sclerosis, Jeremy welcomes back Dr. Neil Thakur, chief mission officer at The ALS Association, for the latest.
To urge the FDA to approve AMX0035 as quickly as possible go to als.org/fda
To read the letter from several dozen ALC clinical experts calling on FDA to make AMX0035 available as a treatment option go to https://www.als.org/stories-news/several-dozen-prominent-als-clinicians-call-fda-approve-amx0035
This episode is brought to you by The ALS Association in partnership with CitizenRacecar.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review